Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.


Latest Press Releases

HepatoBurn Reviews (DOCTOR INVESTIGATES): Does This Liver-Based Fat-Loss Formula Really Work In 2026?
Healthcare & PharmaceuticalAdvertorial

HepatoBurn Reviews (DOCTOR INVESTIGATES): Does This Liver-Based Fat-Loss Formula Really Work In 2026?

January 25, 2026 7:15 PM

If you've been searching for HepatoBurn reviews in 2026, chances are you've already heard the quiet buzz turning into a roar, not from TikTok trends or social media hype, but from real conversations between doctors, nutritionists, and frustrated individuals who've tried every fat burner on the market with little to no long-term success. What's behind the sudden attention? HepatoBurn isn't just another thermogenic or appetite suppressant. It's...

Read more
IQ Blast Pro Reviews (DOCTOR INVESTIGATES): Can This 2026 Neuro Formula Really Boost Memory, Focus & Brain Energy?
Healthcare & PharmaceuticalAdvertorial

IQ Blast Pro Reviews (DOCTOR INVESTIGATES): Can This 2026 Neuro Formula Really Boost Memory, Focus & Brain Energy?

January 25, 2026 1:15 PM

Across the U.S., neurologists are raising alarms about the silent rise of "neural fatigue", a modern epidemic linked to memory lapses, focus problems, and cognitive burnout. In 2025, one supplement called IQ Blast Pro has become the focus of both clinical curiosity and consumer demand. Positioned as a Doctor-Formulated, Stimulant-Free Cognitive Support Formula (Verified), IQ Blast Pro claims to strengthen the brain-blood barrier, what...

Read more
GlucoTrust Bites Reviews (DOCTOR INVESTIAGES) Do These Gluco Trust Gummies Really Support Blood Sugar Balance in 2026?
Healthcare & PharmaceuticalAdvertorial

GlucoTrust Bites Reviews (DOCTOR INVESTIAGES) Do These Gluco Trust Gummies Really Support Blood Sugar Balance in 2026?

January 25, 2026 11:26 AM

Blood sugar supplements rarely introduce anything genuinely new. Most rely on familiar capsules, predictable ingredient lists, and surface-level promises that blur together after a while. GlucoTrust Bites arrived with a noticeably different positioning, and that's precisely why searches for GlucoTrust Bites reviews have spiked. Rather than centering solely on insulin output, GlucoTrust Bites focuses on a lesser-discussed metabolic factor:...

Read more
Java Burn Reviews (DOCTOR INVESTIGATES) Why This Coffee-Based Metabolic Formula Is Back Under Investigation
Healthcare & PharmaceuticalAdvertorial

Java Burn Reviews (DOCTOR INVESTIGATES) Why This Coffee-Based Metabolic Formula Is Back Under Investigation

January 24, 2026 6:00 PM

As 2026 begins, Java Burn reviews are once again climbing search results, not because of hype alone, but because coffee-based metabolic supplements are re-entering serious discussion among consumers who want metabolic efficiency without extreme stimulants. Java Burn, a flavorless coffee additive designed to work with caffeine rather than replace it, has resurfaced as one of the most debated formulas in the category. Unlike traditional fat...

Read more
NeuroPrime Reviews (DOCTOR REVEALS) The Real Reason Liquid Brain Supplements Are Replacing Pills in 2026
Healthcare & PharmaceuticalAdvertorial

NeuroPrime Reviews (DOCTOR REVEALS) The Real Reason Liquid Brain Supplements Are Replacing Pills in 2026

January 24, 2026 1:35 PM

Most people looking up NeuroPrime reviews in 2026 aren't searching for a long experiment. They want to know one thing: Will I feel something, and how fast? That question exists because the cognitive supplement space has trained consumers to expect either instant stimulation or nothing at all. NeuroPrime enters that conversation differently. Rather than relying on caffeine spikes or synthetic stimulants, NeuroPrime uses a sublingual delivery...

Read more
Quantum Brainwave Protocol Review 2026: Hype vs Reality Explained
Healthcare & PharmaceuticalAdvertorial

Quantum Brainwave Protocol Review 2026: Hype vs Reality Explained

January 24, 2026 11:50 AM

This article contains affiliate links. If you purchase through these links, a commission may be earned at no additional cost to you. This does not influence our analysis. The information below reflects the product's marketing materials and publicly available research on audio relaxation technology. This is not medical advice. Consult a healthcare professional before beginning any new wellness practice. Quantum Brainwave Protocol Explained...

Read more
Neuro Serge Reviews (DOCTOR INVESTIGATES) Cognitive Support Benefits, Risks & Who Should Avoid It In 2026
Healthcare & PharmaceuticalAdvertorial

Neuro Serge Reviews (DOCTOR INVESTIGATES) Cognitive Support Benefits, Risks & Who Should Avoid It In 2026

January 24, 2026 11:20 AM

Cognitive decline, brain fog, and focus loss are no longer slow-burning problems, they're immediate performance blockers, and millions are feeling them daily. That urgency is exactly why Neuro Serge Reviews exploded going into 2026. Unlike outdated nootropics that require weeks of buildup, Neuro Serge is widely reported to deliver noticeable cognitive clarity, sharper focus, and mental energy within days, without stimulants, crashes, or side...

Read more
Ireland Acute Care EHR and Digital Health 2026 Report Released
Healthcare & PharmaceuticalProduct Announcements

Ireland Acute Care EHR and Digital Health 2026 Report Released

January 24, 2026 10:30 AM

Black Book Market Research LLC Insights today announced the release of Ireland Acute Care EHR and Digital Health 2026, an Ireland-specific companion report built for executives, clinical informatics leaders, digital transformation teams, and technology suppliers navigating the country's next wave of acute-care EHR modernisation through 2026-2030. The report is available gratis to qualified global healthcare IT stakeholders seeking a...

Read more
Perfect Peptides Review 2026: Is This USA-Based Research Peptide Supplier Legit?
Healthcare & PharmaceuticalAdvertorial

Perfect Peptides Review 2026: Is This USA-Based Research Peptide Supplier Legit?

January 24, 2026 10:20 AM

Disclaimer: This article is for informational purposes only. Perfect Peptides sells research chemicals strictly for laboratory and scientific research purposes. These products are NOT intended for human or animal consumption. Affiliate Disclosure: This article contains affiliate links. If you purchase through these links, a commission may be earned at no additional cost to you. This compensation does not influence the accuracy or integrity of...

Read more
Best NAD+ Injections 2026: What Consumers Should Know About Prescription NAD+ Therapy, Dosage, Benefits & Side Effects - Direct Meds Analysis
Healthcare & PharmaceuticalAdvertorial

Best NAD+ Injections 2026: What Consumers Should Know About Prescription NAD+ Therapy, Dosage, Benefits & Side Effects - Direct Meds Analysis

January 23, 2026 9:40 PM

Affiliate Disclosure: If you purchase through links in this article, a commission may be earned at no additional cost to you. Disclaimer: This article is for informational purposes only and does not constitute medical advice. NAD+ injections require evaluation by a licensed healthcare provider. Always consult a qualified healthcare professional before starting any treatment. Why "Best NAD+ Injections" Has Become the Most Searched NAD+ Term in...

Read more
Onco-Innovations Announces Private Placement
Healthcare & PharmaceuticalCompany Update

Onco-Innovations Announces Private Placement

January 23, 2026 7:00 PM

Onco-Innovations Limited (CBOE CA:ONCO)(Frankfurt:W1H, WKN:A3EKSZ)(OTCQB:ONNVF) ("Onco" or the "Company") announces that it intends to complete a non-brokered private placement (the "Private Placement") of up to 2,272,727 units of the Company (the "Units") at a price of $0.88 per Unit, for aggregate gross proceeds of up to $2,000,000. Each Unit shall consist of one common share (each a "Share") and one-half of one common share purchase warrant...

Read more
Black Book Market Research Publishes Trust Framework to Advance Independent, KPI-Based Benchmarking in Healthcare Technology and Services
Healthcare & PharmaceuticalCompany Update

Black Book Market Research Publishes Trust Framework to Advance Independent, KPI-Based Benchmarking in Healthcare Technology and Services

January 23, 2026 4:30 PM

Black Book Market Research today published the Black Book Trust Framework, a formal standard that defines how the firm designs research programs, benchmarks performance, and recognizes high-performing healthcare technology and services providers. Built for a rapidly globalizing health IT market, the framework is intended to support more defensible evaluation by applying measurable KPIs, published definitions, and continuous...

Read more
Zomedica Expands its TRUVIEW(R) Microscopy Platform with AI Diagnostic Interpretation, Growing its Market Opportunity
Healthcare & PharmaceuticalCompany Update

Zomedica Expands its TRUVIEW(R) Microscopy Platform with AI Diagnostic Interpretation, Growing its Market Opportunity

January 23, 2026 4:01 PM

Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company providing innovative point-of-care diagnostic and therapeutic solutions for equine and companion animals, today announced the integration of advanced artificial intelligence (AI) interpretation capabilities into its TRUVIEW® AI digital microscopy system. The AI enhancement expands functionality of the TRUVIEW system by enabling automated interpretation of...

Read more
Arialief Reviews (URGENT SAFETY REPORT) Real Results, Hidden Complaints & Side Effects In 2026
Healthcare & PharmaceuticalCompany Update

Arialief Reviews (URGENT SAFETY REPORT) Real Results, Hidden Complaints & Side Effects In 2026

January 23, 2026 2:35 PM

Nerve discomfort is no longer a fringe health issue, it's a growing, everyday problem affecting millions of adults worldwide. Burning sensations, tingling in the feet, sharp nerve jolts, and unexplained numbness are now among the most searched health complaints heading into 2026. As frustration with prescriptions, injections, and temporary fixes grows, consumers are actively searching for safer, long-term solutions that support nerve health at...

Read more
Revelation Biosciences Inc. Announces Exercise of Warrants for $11 Million in Gross Proceeds
Healthcare & PharmaceuticalFinancing

Revelation Biosciences Inc. Announces Exercise of Warrants for $11 Million in Gross Proceeds

January 23, 2026 2:10 PM

Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company focused on rebalancing inflammation, announced today the entry into a definitive agreement for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 13,065,000 shares of common stock, issued by the Company on September 11, 2025 (the "Existing Warrants"), at reduced exercise price of $0.86 per...

Read more
Vital Step GLP-1 Weight Loss Program Guide 2026: Injectable vs Oral Options, Pricing, Safety & What to Expect
Healthcare & PharmaceuticalAdvertorial

Vital Step GLP-1 Weight Loss Program Guide 2026: Injectable vs Oral Options, Pricing, Safety & What to Expect

January 23, 2026 1:15 PM

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Compounded medications are not FDA-approved or evaluated for safety, effectiveness, or quality by the FDA. Weight loss concerns should be evaluated by qualified healthcare professionals. Always consult a licensed healthcare professional before starting any prescription treatment. If you purchase through these links, a commission may be earned at...

Read more
Mentavi Health Presented Validation Data for Its Online Adult ADHD Diagnostic Evaluation at APSARD 2026
Healthcare & PharmaceuticalCompany Update

Mentavi Health Presented Validation Data for Its Online Adult ADHD Diagnostic Evaluation at APSARD 2026

January 23, 2026 9:50 AM

Mentavi Health, a telehealth leader in evidence-based digital mental health care, participated in the APSARD 2026 Annual Conference (American Professional Society for ADHD and Related Disorders), held January 15-18, 2026, in San Diego. Mentavi Chief Medical Officer Barry K. Herman, MD, MMM, presented a scientific poster summarizing Mentavi's peer-reviewed validation study of its online, asynchronous, clinician-reviewed diagnostic evaluation for...

Read more
Altamira Therapeutics to Present at mRNA-Based Therapeutics Summit
Healthcare & PharmaceuticalCompany Update

Altamira Therapeutics to Present at mRNA-Based Therapeutics Summit

January 23, 2026 9:00 AM

Altamira Therapeutics Ltd. ("Altamira" or the "Company") (OTCID:CYTOF), a company dedicated to developing and commercializing nucleic acid delivery technology for targets beyond the liver, announced today that it will be presenting at the 5th mRNA-Based Therapeutics Summit Europe, being held January 28-29, 2026, in Berlin. Covadonga Pañeda, Ph.D., Altamira Therapeutics' Chief Operating Officer, will give a presentation entitled "CycloPhore &...

Read more
Medicus Pharma Marks Nasdaq Anniversary With Opening Bell Ceremony
Healthcare & PharmaceuticalCompany Update

Medicus Pharma Marks Nasdaq Anniversary With Opening Bell Ceremony

January 23, 2026 7:30 AM

Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics assets, CEO Dr Raza Bokhari joined Steve Darling from Proactive https://youtu.be/8EErx6aQEXs to announce that the company was honored with the opportunity to ring the Nasdaq Opening Bell at the Nasdaq MarketSite in New York's Times...

Read more
Cantargia Reports First Patient Dosed in New US Investigator-Initiated Colorectal Cancer Study
Healthcare & PharmaceuticalCompany Update

Cantargia Reports First Patient Dosed in New US Investigator-Initiated Colorectal Cancer Study

January 23, 2026 1:50 AM

Cantargia AB (Publ) (STO:CANTA) today reported that the first patient has been dosed in a Phase 1b/2 clinical trial investigating nadunolimab in combination with checkpoint inhibitor therapy in up to 24 patients with chemotherapy-refractory metastatic microsatellite stable (MSS) colorectal cancer (CRC). The study is an investigator-led initiative in collaboration with Dr. Dan Fang at Tisch Cancer Institute, Icahn School of Medicine at Mount...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers • June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?